Safety and Performance of the OTTAVA Robotic System

NCT06709261 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2026-08-13

No results posted yet for this study

Summary

This study assesses safety and performance of the OTTAVA Robotic System, through 30 days postoperative, in subjects undergoing robotic-assisted Roux-en-Y Gastric Bypass (RYGB) procedure.

Conditions

Interventions

DEVICE

OTTAVA Robotic System

Procedure with the OTTAVA Robotic System

Sponsors & Collaborators

  • Auris Health, Inc.

    lead INDUSTRY

Principal Investigators

  • Erik Wilson, MD · Memorial Hermann Texas Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-05
Primary Completion
2025-10-20
Completion
2025-10-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06709261 on ClinicalTrials.gov